Ton N Schumacher

64PUBLICATIONS
337CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunityMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (64)

|Mar 27, 2026
Publisher Correction: Clinical development of cancer vaccines.

John B Haanen, Ton N M Schumacher, Jonathan C Kagan

|Mar 23, 2026
Social status impacts T-cell responses through synapse strength in the prefrontal cortex.

Hui Xiong, Daniel Amado-Ruiz, Tessa R Lodder

|Mar 12, 2026
Clinical development of cancer vaccines.

John B Haanen, Ton N M Schumacher, Jonathan C Kagan

|Feb 18, 2026
Temporal and spatial composition of the tumor microenvironment predicts response to immune checkpoint inhibition in metastatic TNBC.

Noah F Greenwald, Iris Nederlof, Cameron Sowers

|Feb 05, 2026
NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy.

Divya Lenkala, Jessica Kohler, Brian McCarthy

|Nov 18, 2025
Guidelines for T cell nomenclature.

David Masopust, Amit Awasthi, Rémy Bosselut

Pageof 11

Frequent Collaborators

21 joint publications

John G Haanen

12 joint publications

Daniela S Thommen

9 joint publications

Christian U Blank

6 joint publications

Emile E Voest